<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Rheumatol Immunol Res</journal-id><journal-id journal-id-type="iso-abbrev">Rheumatol Immunol Res</journal-id><journal-id journal-id-type="publisher-id">rir</journal-id><journal-id journal-id-type="doi">rir</journal-id><journal-title-group><journal-title>Rheumatology and Immunology Research</journal-title></journal-title-group><issn pub-type="epub">2719-4523</issn><publisher><publisher-name>De Gruyter</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC10729588</article-id><article-id pub-id-type="publisher-id">rir-2023-0032</article-id><article-id pub-id-type="doi">10.2478/rir-2023-0032</article-id><article-categories><subj-group subj-group-type="heading"><subject>Images</subject></subj-group></article-categories><title-group><article-title>Role of ultrasound in guiding the biopsy site in eosinophilic fasciitis</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7485-471X</contrib-id><name><surname>Galluccio</surname><given-names>Felice</given-names></name><email xlink:href="mailto:felicegalluccio@gmail.com">felicegalluccio@gmail.com</email><xref rid="j_rir-2023-0032_aff_001" ref-type="aff"/><xref rid="j_rir-2023-0032_aff_002" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Cassisa</surname><given-names>Angelo</given-names></name><xref rid="j_rir-2023-0032_aff_003" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Matucci-Cerinic</surname><given-names>Marco</given-names></name><xref rid="j_rir-2023-0032_aff_004" ref-type="aff"/></contrib><aff id="j_rir-2023-0032_aff_001"><institution>Fisiotech Lab Studio, Rheumatology and Pain Management</institution>, <city>Firenze</city>, <country country="IT">Italy</country></aff><aff id="j_rir-2023-0032_aff_002"><institution>Morphological Madrid Research Center (MoMaRC)</institution>, <city>Madrid</city>, <country country="ES">Spain</country></aff><aff id="j_rir-2023-0032_aff_003"><institution>Department of Anatomopathology, Ospedale San Giovanni di Dio</institution>, <city>Florence</city>, <country country="IT">Italy</country></aff><aff id="j_rir-2023-0032_aff_004"><institution>Unit of Immunology, Rheumatology, Allergy and Rare diseases, IRCCS San Raffaele Hospital</institution>, <city>Milan</city>, <country country="IT">Italy</country></aff></contrib-group><author-notes><corresp><sup>*</sup>Felice Galluccio, M.D., Fisiotech Lab Studio, Via Giovanni Lanza 56, 50136, Firenze, Italy</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>12</month><year>2023</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2023</year></pub-date><volume>4</volume><issue>4</issue><fpage>219</fpage><lpage>221</lpage><history><date date-type="received"><day>13</day><month>8</month><year>2023</year></date><date date-type="accepted"><day>9</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; 2023 Felice Galluccio, Angelo Cassisa, Marco Matucci-Cerinic, published by De Gruyter on behalf of NCRC-DID</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Felice Galluccio, Angelo Cassisa, Marco Matucci-Cerinic, published by De Gruyter on behalf of NCRC-DID</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under the Creative Commons Attribution 4.0 International License.</license-p></license></permissions><funding-group><funding-statement><italic toggle="yes">None</italic>.</funding-statement></funding-group><counts><page-count count="3"/></counts></article-meta></front><body><p>A 60 sixty-year-old woman presented with stiffness and pain in upper and lower limbs started 7 months earlier, followed by non-pitting edema in the forearms and legs extending centripetally. She also reports progressive asthenia with difficulty carrying out normal daily and work activities. Nothing significant in the medical history, no known family history of rheumatic diseases. Acute-phase reactants, autoantibodies, and leukocyte formula were normal and only an increase of &#x003b2;2-microglobulin (5.29 mg/L normal range 0.97&#x02013;2.64) and gammaglobulin (24.4% normal range 10.6&#x02013;18.8) with biclonal IgG chains was detected.</p><p>The thigh biopsy (<xref rid="j_rir-2023-0032_fig_001" ref-type="fig">Figure 1A</xref>, black arrow) detecting only a minimal inflammatory infiltrate and sparse collagen fibers, did not allow any specific diagnosis. The ultrasound (US) scanning of the vastus lateralis muscle (<xref rid="j_rir-2023-0032_fig_001" ref-type="fig">Figure 1B</xref> and <xref rid="j_rir-2023-0032_fig_001" ref-type="fig">1C</xref>, vastus lateralis muscle (VLM)) identified a diffuse thickening of the fascia (<xref rid="j_rir-2023-0032_fig_001" ref-type="fig">Figure 1B</xref> and <xref rid="j_rir-2023-0032_fig_001" ref-type="fig">1C</xref>, asterisk) and hypodermic septa (<xref rid="j_rir-2023-0032_fig_001" ref-type="fig">Figure 1B</xref> and <xref rid="j_rir-2023-0032_fig_001" ref-type="fig">1C</xref>, arrowhead), as well as focal areas of fluid separation of the fascia from the surrounding tissues (<xref rid="j_rir-2023-0032_fig_001" ref-type="fig">Figure 1B</xref> and <xref rid="j_rir-2023-0032_fig_001" ref-type="fig">1C</xref>, white arrow): the area was hyperechoic with a loss of muscle echostructure, due to focal areas of greater inflammatory involvement. The new biopsy, performed in this area (<xref rid="j_rir-2023-0032_fig_001" ref-type="fig">Figure 1A</xref>, red dotted circle), showed a fascial thickening (<xref rid="j_rir-2023-0032_fig_001" ref-type="fig">Figure 1F</xref> and <xref rid="j_rir-2023-0032_fig_001" ref-type="fig">1G)</xref> with hypodermic septa (<xref rid="j_rir-2023-0032_fig_001" ref-type="fig">Figure 1D</xref>, arrowhead), and a lymphoplasmacytic infiltrate characterized by an eosinophilic accumulation (<xref rid="j_rir-2023-0032_fig_001" ref-type="fig">Figure 1E, 1F</xref> and <xref rid="j_rir-2023-0032_fig_001" ref-type="fig">1G)</xref>, thus suggesting the diagnosis of eosinophilic fasciitis.<sup>[<xref rid="j_rir-2023-0032_ref_001" ref-type="bibr">1</xref>]</sup></p><fig position="float" id="j_rir-2023-0032_fig_001" fig-type="figure"><label>Figure 1</label><caption><p>A. Patient&#x02019;s right thigh; Black arrow: previous biopsy site; Red dotted circle: biopsied area corresponding to ultrasound findings. B-C. Ultrasound transverse (B) and longitudinal (C) scans; sc: subcutaneous tissue; *: thickening of the fascia; VLM: vastus lateralis muscle; arrowhead: thickening of hypodermic septa; white arrow: fluid collection between fascia and muscle. D-E-F-G. Histology findings: thickened hypodermic septa (arrowhead), lymphoplasmacytic, and eosinophils (E-F-G) on thickened fascia (F-G). H-I. Post-treatment ultrasound transverse scan; dotted circle: biopsied area. *: fascia and resolution of perifascial fluid collection; arrowhead: note the reduction of the thickness of the hypodermic septa and of the subcutaneous tissue; negative PD signal. Colorized versions of ultrasound images (J) before and (K) after treatment, demonstrating the echostructure improvement useful for patient monitoring.</p></caption><graphic xlink:href="j_rir-2023-0032_fig_001" position="float"/></fig><p>The patient was treated with methylprednisolone sodium succinate 500 mg intravenously (IV) pulses for three consecutive days, followed by oral methylprednisolone 16 mg/day combined with methotrexate 10 mg/week. Pulsed therapy with steroids was chosen to try to block the extension of the disease more rapidly, which had also affected the trunk and neck. After two months of treatment, despite the progressive reduction of cortisone up to 4 mg/day, the altered values of gamma globulins (17%) and 2-microglobulin (2.40 mg/L) normalized. The area of interest was followed up with US, showing the resolution of the perifascial fluid collection [<xref rid="j_rir-2023-0032_fig_001" ref-type="fig">Figure 1H-1I</xref> asterisk], the reduction of the thickness of the hypodermic septa [<xref rid="j_rir-2023-0032_fig_001" ref-type="fig">Figure 1J</xref> and <xref rid="j_rir-2023-0032_fig_001" ref-type="fig">1K]</xref> and of the subcutaneous tissue. This case highlights the role that US may have in identifying the site where to perform the biopsy in a patchy disease distribution like fasciitis. Thus, US may help either in the diagnostic procedure to choose an area of disease activity and in the follow up to evaluate directly at patient bedside the therapeutic efficacy.<sup>[<xref rid="j_rir-2023-0032_ref_002" ref-type="bibr">2</xref>]</sup> Among imaging methods, magnetic resonance imaging (MRI) is probably superior in detecting abnormalities of eosinophilic fasciitis,<sup>[<xref rid="j_rir-2023-0032_ref_003" ref-type="bibr">3</xref>]</sup> but ultrasound is superior overall because it is cost-effective, has virtually no contraindications and is certainly much better accepted by patients, being able to use it from diagnosis to biopsy guide up to the entire follow-up.</p></body><back><ack id="j_rir-2023-0032_ack_001"><title>Acknowledgment</title><p><italic toggle="yes">None</italic>.</p></ack><fn-group><fn fn-type="con" id="j_rir-2023-0032_fn_101"><p>
<bold>Author Contributions</bold>
</p><p><italic toggle="yes">FG performed ultrasound and biopsy, set up treatment and follow-up. FG wrote the first version of the paper and proofread it before submission. AC performed the histopathological examination and participated in the critical review of the article. MMC Participated in the drafting of the article and critically reviewed the work before submission. All three authors approved the final version to be published</italic>.</p></fn><fn fn-type="COI-statement" id="j_rir-2023-0032_fn_102"><p>
<bold>Conflict of Interest</bold>
</p><p><italic toggle="yes">Marco Matucci-Cerinic is an Associate Editor-in-Chief of the journal. This article was subject to the journal&#x02019;s standard procedures, with peer review handled independently of the editor and his research group</italic>.</p></fn><fn fn-type="other" id="j_rir-2023-0032_fn_103"><p>
<bold>Ethical Approval</bold>
</p><p><italic toggle="yes">Not applicable</italic>.</p></fn><fn fn-type="other" id="j_rir-2023-0032_fn_105"><p>
<bold>Informed Consent</bold>
</p><p><italic toggle="yes">Images are de-identified; however the patient has signed her consent to the publication of the images, her data and her clinical history</italic>.</p></fn></fn-group><ref-list><title>References</title><ref id="j_rir-2023-0032_ref_001"><label>[1]</label><element-citation publication-type="journal"><name><surname>Shulman</surname><given-names>LE</given-names></name><article-title>Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome?</article-title><source>J Rheumatol</source><year>1984</year><volume>11</volume><fpage>569</fpage><comment>-</comment><lpage>570</lpage><pub-id pub-id-type="pmid">6542592</pub-id>
</element-citation></ref><ref id="j_rir-2023-0032_ref_002"><label>[2]</label><element-citation publication-type="journal"><name><surname>Au Eong</surname><given-names>DTM</given-names></name><name><surname>Cronin</surname><given-names>O</given-names></name><name><surname>Biswas</surname><given-names>A</given-names></name><name><surname>McKay</surname><given-names>ND</given-names></name><article-title>Ultrasound in the diagnosis and monitoring of eosinophilic fasciitis</article-title><source>Rheumatology (Oxford)</source><year>2021</year><volume>60</volume><fpage>e107</fpage><comment>-</comment><lpage>e108</lpage><pub-id pub-id-type="pmid">33099646</pub-id>
</element-citation></ref><ref id="j_rir-2023-0032_ref_003"><label>[3]</label><element-citation publication-type="journal"><name><surname>Chohan</surname><given-names>S</given-names></name><name><surname>Wong</surname><given-names>N</given-names></name><name><surname>Hanson</surname><given-names>J</given-names></name><name><surname>Darwish</surname><given-names>M</given-names></name><name><surname>Osto</surname><given-names>M</given-names></name><name><surname>Daveluy</surname><given-names>S</given-names></name><article-title>Diagnostic imaging for eosinophilic fasciitis: A systematic review</article-title><source>JAAD Int</source><year>2023</year><volume>13</volume><fpage>10</fpage><comment>-</comment><lpage>12</lpage><pub-id pub-id-type="pmid">37575513</pub-id>
</element-citation></ref></ref-list></back></article>
